БОРТЕКСА САН

ਉਤਪਾਦ ਝਲਕ

About БОРТЕКСА САН

БОРТЕКСА САН is a prescription medication containing the active ingredient Bortezomib, a proteasome inhibitor used in the treatment of certain types of blood cancers, including multiple myeloma and mantle cell lymphoma. It works by blocking the action of proteasomes, which are complexes that break down proteins in cells.

Key Benefits & Uses

• Treatment of multiple myeloma, a type of blood cancer characterized by the proliferation of malignant plasma cells in the bone marrow.
• Treatment of mantle cell lymphoma, a rare type of non-Hodgkin lymphoma.
• Induction of a response in patients with relapsed or refractory multiple myeloma.

Active Ingredient & Action

Bortezomib, the active ingredient in БОРТЕКСА САН, works by inhibiting the 26S proteasome, a complex that breaks down proteins in cells. This leads to an accumulation of defective proteins, triggering apoptosis (cell death) in cancer cells. Bortezomib also has immunomodulatory effects, enhancing the body's immune response against cancer cells.

Important Notes

БОРТЕКСА САН is available in injectable form and should be administered under the guidance of a healthcare professional. Common side effects include fatigue, nausea, diarrhea, and peripheral neuropathy. Patients with a history of cardiovascular disease, liver or kidney impairment, or hypersensitivity to Bortezomib should use this medication with caution. Consult a healthcare professional for a complete list of indications, contraindications, and potential side effects.